Home/Filings/4/0001628280-24-051352
4//SEC Filing

FEBBO WILLIAM J 4

Accession 0001628280-24-051352

CIK 0001448431other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 2:28 PM ET

Size

5.4 KB

Accession

0001628280-24-051352

Insider Transaction Report

Form 4
Period: 2024-12-12
FEBBO WILLIAM J
DirectorCEO
Transactions
  • Purchase

    Common Stock

    2024-12-12$5.01/sh+20,000$100,220601,253 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.01 to $5.05. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001413987

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 2:28 PM ET
Size
5.4 KB